Schwab Charles CORP Form 4 insider transactions

Charles Schwab's Chief Risk Officer, Nigel J. Murtagh, executed a pre-planned transaction, exercising stock options and immediately selling the acquired common stock.

Charles Schwab Corporation Director Joan Dea reported a pre-planned disposition of 513 common stock shares as a gift, effective July 29, 2025.

Carolyn Schwab-Pomerantz, a Director at Charles Schwab Corp., reported the sale of 24,000 shares of common stock on July 3, 2025, executed through a pre-arranged Rule 10b5-1 trading plan.

Charles A. Ruffel, a Director at The Charles Schwab Corporation, acquired 1,322 nonqualified stock options with an exercise price of $91.17, vesting immediately, as part of his director compensation.

Charles Schwab Director Frank Herringer acquired 227 Restricted Stock Units and 909 Nonqualified Stock Options on July 1, 2025, as part of his director compensation plan.

Stephen A. Ellis, a Director at Charles Schwab Corporation, acquired 371 Restricted Stock Units on July 1, 2025, as part of a deferred compensation plan, bringing his total beneficial ownership to 11,626.64 RSUs.

Marianne Catherine Brown, a Director at The Charles Schwab Corporation, acquired 412 Restricted Stock Units on July 1, 2025, as part of her deferred compensation plan.

Jonathan S. Beatty, MD and Head of Advisor Services at Charles Schwab, reported the disposition of 1,035 shares of common stock for tax withholding purposes related to restricted stock unit settlement.

Paul V. Woolway, Managing Director and Chief Banking Officer of Charles Schwab Corp., sold 3,290 shares of common stock for approximately $90.95 per share as part of a pre-established Rule 10b5-1 trading plan.

Stephen A. Ellis, a Director at Charles Schwab Corporation, exercised stock options to acquire 1,853 shares of common stock and subsequently transferred these and additional shares to a revocable trust.

Charles Schwab's Chief Risk Officer, Nigel J. Murtagh, exercised stock options and subsequently sold an equivalent number of shares on June 18, 2025, under a pre-arranged 10b5-1 trading plan.

Paul V. Woolway, MD, Chief Banking Officer at Charles Schwab, exercised stock options and subsequently sold the acquired shares on June 18, 2025, as part of a Rule 10b5-1 trading plan.

Carolyn Schwab-Pomerantz, a Director and 10% owner of Charles Schwab Corp., sold 24,000 shares of common stock for approximately $2.09 million on June 5, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Charles Schwab's Chief Financial Officer, Michael D. Verdeschi, reported the disposition of 5,888 shares of common stock at $87.54 per share, withheld for tax obligations related to the vesting of restricted stock units.

Paul V. Woolway, MD and Chief Banking Officer of The Charles Schwab Corporation, sold 3,290 shares of common stock for approximately $288,300 under a Rule 10b5-1 trading plan.

Jonathan S. Beatty, MD and Head of Advisor Services at Charles Schwab, sold 2,850 shares of common stock for approximately $249,572 under a Rule 10b5-1 trading plan.

Charles Schwab's Chief Risk Officer, Nigel J. Murtagh, exercised 25,000 stock options and simultaneously sold an equal number of common shares for a significant profit on May 28, 2025.

Charles Schwab Corporation Director Todd M. Ricketts reported the acquisition of restricted stock units and nonqualified stock options, alongside a transfer of shares between trusts, as detailed in a recent SEC Form 4 filing.

Gerri Martin-Flickinger, a Director at The Charles Schwab Corporation, was granted 1,462 restricted stock units and options to purchase 3,646 shares of common stock as part of the company's 2022 Stock Incentive Plan.

A director at Charles Schwab Corporation has disclosed the sale of common stock alongside the acquisition of new restricted stock units and nonqualified stock options.

Charles Schwab Corporation Director Carolyn Schwab-Pomerantz was granted 1,462 restricted stock units and 3,646 nonqualified stock options under the company's 2022 Stock Incentive Plan.

A director at The Charles Schwab Corporation, Arun Sarin, has been granted restricted stock units and nonqualified stock options as part of the company's 2022 Stock Incentive Plan.

Charles A. Ruffel, a Director at The Charles Schwab Corporation, has reported the acquisition of restricted stock units and nonqualified stock options as part of the company's 2022 Stock Incentive Plan.

Charles Schwab Corporation Director Frank C. Herringer was granted 1,462 restricted stock units and 3,646 nonqualified stock options on May 27, 2025, as part of the company's 2022 Stock Incentive Plan.

Charles Schwab Corporation Director Stephen A. Ellis was granted 1,462 restricted stock units and 3,646 nonqualified stock options on May 27, 2025, as part of the company's 2022 Stock Incentive Plan.

Christopher V. Dodds, a Director at Charles Schwab Corp., was granted 1,462 restricted stock units and 3,646 nonqualified stock options on May 27, 2025, as part of the company's 2022 Stock Incentive Plan.

Charles Schwab Corporation Director Joan Dea was granted 1,462 restricted stock units and options to purchase 3,646 shares of common stock on May 27, 2025, as part of the company's 2022 Stock Incentive Plan.

Marianne Catherine Brown, a Director at Charles Schwab Corporation, was granted 1,462 restricted stock units and 3,646 nonqualified stock options on May 27, 2025, as part of the company's 2022 Stock Incentive Plan.

A recent SEC Form 4 filing reveals that John K. Adams Jr., a Director at The Charles Schwab Corporation, was granted 1,462 restricted stock units and 3,646 nonqualified stock options as part of the company's 2022 Stock Incentive Plan.

Charles R. Schwab, Co-Chairman of The Charles Schwab Corporation, has reported the sale of 34,585 shares of common stock for approximately $3.02 million, executed under a Rule 10b5-1 trading plan.